MPS IV A
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI (NCT03632213) | Hospital de Clinicas de Porto Alegre | 2018-11-07 |
| A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) (NCT01275066) | BioMarin Pharmaceutical | 2011-02-01 |
| A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) (NCT01242111) | BioMarin Pharmaceutical | 2010-11-01 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA (NCT00884949) | BioMarin Pharmaceutical | 2009-04-01 |
| A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome) (NCT00787995) | BioMarin Pharmaceutical | 2008-10-01 |
Track MPS IV A automatically
Every clearance here is in the API, with alerts when new ones post.